Can I read Nateglinide vs Valsartan in IGT Study on EtoBox?
Nateglinide vs Valsartan in IGT Study by CardiologyNetwork.com is a document available to read on EtoBox.
What is Nateglinide vs Valsartan in IGT Study about?
1) The NAVIGATOR trial evaluated whether nateglinide or valsartan could reduce the risk of diabetes and cardiovascular disease in people with impaired glucose tolerance. 2) Nateglinide reduced post-meal glucose levels but increased fasting plasma glucose and weight compared to placebo. 3) There was no significant difference in the incidence of diabetes or cardiovascular outcomes between the nateglinide and placebo groups after adjusting for multiple comparisons.
- Author
- CardiologyNetwork.com
- Language
- EN